CRESCINA TRANSDERMIC HFSC MAN 1300
COMPLETE TREATMENT FOR HAIR GROWTH AND AGAINST HAIR LOSS
Men's Formula – For advanced stages of thinning and very severe hair loss
100% Formula
Activates the natural growth of hair in areas of thinning.
Effective in 100% of individuals tested*.
With active ingredients of transdermal technology
Crescina Growth has been over time a dermato-cosmetic treatment for topical application focused on addressing hair thinning, activating the natural growth of hair and is not just another anti-hair loss product aimed at slowing down or preventing the detachment of existing hairs on the scalp. Crescina Transdermic Growth HFSC is designed to prevent and address thinning caused by physiological (non-pathological) causes and for cases where the quantity and quality of hair gradually decrease due to reduced activity of hair follicles.
Crescina Transdermic HFSC Complete Treatment for Growth and Against Hair Loss Man 1300 combines in one package two formulations, Crescina Transdermic Growth HFSC and Crescina Transdermic Against Hair Loss. It is a specially designed men's formula for advanced stages of thinning and for very severe hair loss and is available in a package with 10+10 ampoules (one month treatment). The ampoules contain 3.5 ml of formulation.
The patented formulation, thanks to Labo's Transdermal Technology, allows the active molecules to penetrate the hair system not only through the hair follicles but also transdermally, that is through the layers of the scalp (epidermis and dermis). Thanks to their low molecular weight and the presence of 3 absorption enhancers, the penetration and efficacy of the functional active ingredients are facilitated. The treatment achieves a comprehensive action on all hair structures and its formulation enhances the natural growth of hair and acts against hair loss in healthy and semi-dormant follicles.
*EFFECTIVE IN 100% OF THOSE TESTED:
Result after 4 months in the context of in vivo clinical/in-vitro double-blind randomized controlled study with placebo in 46 individuals (of which 23 were administered the Crescina HFSC formulation and the remaining 23 the placebo). The men tested had thinning stages II, III, III vertex and IV on the Hamilton-Norwood scale. Positive results were recorded in all individuals, specifically new hair growth from +7 to +41 in electronically counted area of 1.8 cm². The results of the study are statistically significant. GROWTH OF 6,300 NEW HAIRS on average after 4 months of treatment with Crescina HFSC 100%. Instrumental analysis performed with phototrichogram.
Dermatologically tested formula.
96 
